Abstract:As a member of the ATP-dependent membrane transport proteins, P-Glycoprotein (P-gp) is known to pump substrates out of cells using an ATP-dependent mechanism. The overexpression of P-gp in tumor cells reduces the intracellular drug concentrations, which decreases the efficacy of extensive antitumor drugs and leads to multidrug resistance (MDR) clinically. The combination of anticancer drugs with P-gp inhibitor has been an attractive and promising strategy to reverse MDR in cancer treatment. However, nonspecific or nonselective distribution of P-gp inhibitors to nontarget organs is one of the most fatal shortcomings in clinical application. Thus, there is an urgent need for effective and nontoxic MDR reversal agents, particularly in P-gp–mediated MDR. Traditional Chinese medicine (TCM) natural products may prove less toxic for use in P-gp inhibition to promote MDR reversal. P-gp modulatory effects have been previously demonstrated using selected TCM, including the flavonoid, alkaloid, terpenoid, coumarin, and quinonoid compounds, and some Chinese medicine extracts. Moreover, the approaches for screening active components from TCM are necessary, and these approaches face challenges. At present, the approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods. This review will provide an overview and update on the role of TCM in overcoming P-gp–mediated MDR and the approaches to study the interaction between TCM and P-gp. SIGNIFICANCE STATEMENT This review summarized some traditional Chinese medicines identified to have a modulatory effect on P-gp, including flavonoids, alkaloids, terpenoids, coumarins, quinonoid compounds, and some Chinese medicine extracts, and it introduced possible mechanisms. The approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods.

Research Advance on P-glycoprotein Inhibitors and the Structure-Activity Relationship

Recent developments of P-glycoprotein inhibitors and its structure-activity relationship (SAR) studies

Research Advances in P-glycoprotein

[Recent Advance in the Mechanism Study of Polymeric Inhibitors of P-glycoprotein].

Recent Advances in the Research of P-glycoprotein Inhibitors.

The Effects of Traditional Chinese Medicine on P-Glycoprotein–Mediated Multidrug Resistance and Approaches for Studying the Herb–P-Glycoprotein Interactions

Research on Structure-Activity Relationship of Inhibitory Effects of Flavonoid Derivatives on P-glycoprotein

Structure-activity Relationships Andin Silicomodels of P-glycoprotein (ABCB1) Inhibitors

New Strategies for Research and Development of P-glycoprotein Inhibitors against Tumor Multidrug Resistance

Multidrug resistance inhibitors targeting P-glycoprotein

Medicinal Chemistry Strategies to Discover P-glycoprotein Inhibitors: an Update

Research progress of P-glycoprotein induction

Application of Pharmaceutical Technique to Inhibiting P-glycoprotein-mediated Drug-efflux

Research Progress on P-glycoprotein-mediated Drug Interactions

Structure-ATPase Activity Relationship of Rhodamine Derivatives as Potent Inhibitors of P-Glycoprotein CmABCB1

Combined Qsar and Molecule Docking Studies on Predicting P-Glycoprotein Inhibitors

Structure–Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations

Advances in Inhibitor of P-Glycoprotein

Progress in Search for Interactions Between P-glycoprotein and Central Depressants

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

On Interactions of P-glycoprotein with Various Anti-Tumor Drugs by Binding Free Energy Calculations